FGFR3 dependency and drugs in one query
FGFR3 dependency and drugs from seven public layers: 6 of 1178 DepMap lines depend on it, 32 drugs are listed, and bladder carcinoma is a top disease.
Blog
Worked examples from BioQ: genes, drugs, trials, structures and papers searched across 97 bio databases — with the real results, the sources and the exact query to repeat.
FGFR3 dependency and drugs from seven public layers: 6 of 1178 DepMap lines depend on it, 32 drugs are listed, and bladder carcinoma is a top disease.
A new JCB paper links PIKfyve inhibition to LRRK2 via ClC-7; here is what DepMap, Open Targets, ChEMBL, STRING and TCGA show for LRRK2 as of 2026-11-06.
NCT07811401 tests lemborexant in postoperative sleep disturbance; BioQ adds ChEMBL potency and 22 ClinicalTrials.gov studies, data as of 2026-11-06.
One BioQ query for ALK returns exact ChEMBL measurements, 17 known drugs and 6477 IC50 values from several sources, as of 2026-11-06, in 1.96 engine seconds.
CDK2 is common essential in DepMap Chronos, has 37 known drugs and ties most to neurodegeneration in Open Targets; one BioQ query, data as of 2026-11-06.
A 2026 PLoS ONE paper on Grb2 phosphorylation and EGFR condensates, placed in context with DepMap, ChEMBL, Open Targets and CIViC data as of 2026-11-06.
Phase 2 trial NCT07728851 tests nebulized ketamine in children with acute asthma; BioQ adds ChEMBL potency data and 682 registered ketamine trials.
One query, osimertinib, returns phase counts for 188 registered ClinicalTrials.gov studies and a status table, with EGFR drug context, as of 2026-11-06.
EGFR vs ERBB2 in DepMap Chronos data and drug annotations: 224 of 1178 EGFR-dependent lines versus 177 for ERBB2, and 118 versus 59 known drugs.
A 2026 Cancer Letters paper on CDK9 degradation in gastroesophageal cancer, placed in context with DepMap, ChEMBL, Open Targets, TCGA and STRING data.
Script a gene-to-drug lookup with the BioQ REST API: one call for TP53 returns 18 drugs with stage and pChEMBL potency, data as of 2026-11-06.
NCT07895017 tests avatrombopag around CAR T-cell therapy; BioQ adds ChEMBL potency, 38 registered avatrombopag trials and compound identity, as of 2026-11-06.